PureTech Health Future Growth
Future criteria checks 2/6
PureTech Health's earnings are forecast to decline at 13% per annum while its annual revenue is expected to grow at 45.4% per year. EPS is expected to decline by 14.1% per annum. Return on equity is forecast to be -38.6% in 3 years.
Key information
-13.0%
Earnings growth rate
-14.1%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 45.4% |
| Future return on equity | -38.6% |
| Analyst coverage | Low |
| Last updated | 19 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 27 | -136 | -140 | -140 | 3 |
| 12/31/2025 | 14 | -122 | -175 | -135 | 3 |
| 12/31/2024 | 12 | -128 | -106 | -129 | 3 |
| 6/30/2024 | 0 | -82 | -121 | -121 | N/A |
| 3/31/2024 | 2 | -74 | -114 | -113 | N/A |
| 12/31/2023 | 3 | -66 | -106 | -106 | N/A |
| 9/30/2023 | 8 | -56 | -132 | -131 | N/A |
| 6/30/2023 | 12 | -47 | -157 | -157 | N/A |
| 3/31/2023 | 14 | -49 | -169 | -168 | N/A |
| 12/31/2022 | 16 | -50 | -181 | -179 | N/A |
| 9/30/2022 | 17 | -32 | -183 | -179 | N/A |
| 6/30/2022 | 19 | -14 | -185 | -180 | N/A |
| 3/31/2022 | 18 | -37 | -174 | -169 | N/A |
| 12/31/2021 | 17 | -61 | -164 | -158 | N/A |
| 9/30/2021 | 14 | -127 | -156 | -150 | N/A |
| 6/30/2021 | 11 | -193 | -147 | -141 | N/A |
| 3/31/2021 | 11 | -94 | -142 | -136 | N/A |
| 12/31/2020 | 12 | 6 | -137 | -132 | N/A |
| 9/30/2020 | 12 | 239 | -121 | -115 | N/A |
| 6/30/2020 | 12 | 472 | -104 | -99 | N/A |
| 3/31/2020 | 11 | 446 | -107 | -99 | N/A |
| 12/31/2019 | 10 | 421 | -111 | -98 | N/A |
| 9/30/2019 | 15 | 229 | -103 | -91 | N/A |
| 6/30/2019 | 20 | 37 | -96 | -84 | N/A |
| 3/31/2019 | 20 | -3 | -87 | -78 | N/A |
| 12/31/2018 | 21 | -44 | -77 | -73 | N/A |
| 9/30/2018 | 14 | 9 | -84 | -81 | N/A |
| 6/30/2018 | 7 | 61 | -91 | -88 | N/A |
| 3/31/2018 | 5 | 44 | N/A | -88 | N/A |
| 12/31/2017 | 3 | 26 | N/A | -89 | N/A |
| 9/30/2017 | 4 | -17 | N/A | -81 | N/A |
| 6/30/2017 | 5 | -61 | N/A | -74 | N/A |
| 3/31/2017 | 5 | -55 | N/A | -66 | N/A |
| 12/31/2016 | 4 | -49 | N/A | -58 | N/A |
| 9/30/2016 | 3 | -54 | N/A | -57 | N/A |
| 6/30/2016 | 1 | -59 | N/A | -55 | N/A |
| 3/31/2016 | 6 | -49 | N/A | -42 | N/A |
| 12/31/2015 | 12 | -39 | N/A | -29 | N/A |
| 9/30/2015 | 12 | -37 | N/A | -19 | N/A |
| 6/30/2015 | 12 | -35 | N/A | -9 | N/A |
| 3/31/2015 | 7 | -38 | N/A | -10 | N/A |
| 12/31/2014 | 2 | -42 | N/A | -11 | N/A |
| 12/31/2013 | 9 | -5 | N/A | -9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PTCH.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PTCH.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PTCH.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PTCH.F's revenue (45.4% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: PTCH.F's revenue (45.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PTCH.F is forecast to be unprofitable in 3 years.